Citation Tools
Case Report
Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response